| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA1250276 | B | Inhibition of CDK4 | 21 | ALA1240533 | single protein format | Scientific Literature | ||
| 2. | ALA1250277 | B | Inhibition of CDK6 | 1 | ALA1240533 | single protein format | Scientific Literature | ||
| 3. | ALA1250278 | B | Inhibition of CDK5 | 9 | ALA1240533 | single protein format | Scientific Literature | ||
| 4. | ALA1250280 | B | Inhibition of CDK1 | 23 | ALA1240533 | single protein format | Scientific Literature | ||
| 5. | ALA1250281 | B | Inhibition of CDK2 | 26 | ALA1240533 | single protein format | Scientific Literature | ||
| 6. | ALA2363477 | F | SANGER: Inhibition of human NCI-H1581 cell growth in a cell viability assay. | Homo sapiens | 137 | ALA1201861 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | |
| 7. | ALA2363480 | F | SANGER: Inhibition of human NCI-H1648 cell growth in a cell viability assay. | Homo sapiens | 133 | ALA1201861 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | |
| 8. | ALA2363481 | F | SANGER: Inhibition of human NCI-H1650 cell growth in a cell viability assay. | Homo sapiens | 134 | ALA1201861 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | |
| 9. | ALA2363485 | F | SANGER: Inhibition of human NCI-H1694 cell growth in a cell viability assay. | Homo sapiens | 77 | ALA1201861 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | |
| 10. | ALA2363489 | F | SANGER: Inhibition of human NCI-H1770 cell growth in a cell viability assay. | Homo sapiens | 129 | ALA1201861 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | |
| 11. | ALA2363492 | F | SANGER: Inhibition of human NCI-H1838 cell growth in a cell viability assay. | Homo sapiens | 134 | ALA1201861 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | |
| 12. | ALA2363493 | F | SANGER: Inhibition of human NCI-H187 cell growth in a cell viability assay. | Homo sapiens | 77 | ALA1201861 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | |
| 13. | ALA2363494 | F | SANGER: Inhibition of human NCI-H1882 cell growth in a cell viability assay. | Homo sapiens | 77 | ALA1201861 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | |
| 14. | ALA2363495 | F | SANGER: Inhibition of human NCI-H1963 cell growth in a cell viability assay. | Homo sapiens | 77 | ALA1201861 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | |
| 15. | ALA2363502 | F | SANGER: Inhibition of human NCI-H2081 cell growth in a cell viability assay. | Homo sapiens | 77 | ALA1201861 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | |
| 16. | ALA2363504 | F | SANGER: Inhibition of human NCI-H209 cell growth in a cell viability assay. | Homo sapiens | 125 | ALA1201861 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | |
| 17. | ALA2363505 | F | SANGER: Inhibition of human NCI-H2107 cell growth in a cell viability assay. | Homo sapiens | 31 | ALA1201861 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | |
| 18. | ALA2363507 | F | SANGER: Inhibition of human NCI-H2126 cell growth in a cell viability assay. | Homo sapiens | 134 | ALA1201861 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | |
| 19. | ALA2363508 | F | SANGER: Inhibition of human NCI-H2141 cell growth in a cell viability assay. | Homo sapiens | 77 | ALA1201861 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | |
| 20. | ALA2363510 | F | SANGER: Inhibition of human NCI-H2171 cell growth in a cell viability assay. | Homo sapiens | 77 | ALA1201861 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer |
The page will load shortly, Thanks for your patience!